BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. PDX1, Fatty acid metabolic process, Arthritis, Kidney, Anticancer prodrugs, rs2230926)
Bookmark Forward

QuickView for Lmp2;jsessionid=FF4B57091F5497FDE7B2E01A7009010E;jsessionid=2B4B6BA211D05180BD68E601BB29FDCF (gene)


Body Atlas

Most Correlated Tissues

  1. T Lymphocyte (regulatory) of peripheral blood
  2. Neutrophil of bone marrow
  3. Whole blood
  4. Leukocyte (polymorphonuclear) of peripheral blood
  5. Natural killer cell of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Disorder of lymph node
  2. Ulceration of intestine
  3. Body temperature finding
  4. Subcutaneous fat disorder
  5. Bacterial sepsis of newborn
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Methomyl
  2. Selenium
  3. perfluorodecanoic acid
  4. TGFB2 protein, human
  5. ustekinumab
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Pdgfrb
  2. MIR22
  3. CTCFL
  4. IRF2
  5. RAD54L
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Immunoproteasome Subunit Low Molecular Mass Peptide 2 (LMP2) Deficiency Ameliorates LPS/Aβ1-42-Induc…
  2. A lipid-based LMP2-mRNA vaccine to treat nasopharyngeal carcinoma.
  3. Co-inhibition of immunoproteasome subunits LMP2 and LMP7 enables prevention of transplant arterioscl…
  4. Immunoproteasome-specific subunit PSMB9 induction is required to regulate cellular proteostasis upon…
  5. Immune Characteristics and Prognosis Analysis of the Proteasome 20S Subunit Beta 9 in Lower-Grade Gl…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for Lmp2;jsessionid=FF4B57091F5497FDE7B2E01A7009010E;jsessionid=2B4B6BA211D05180BD68E601BB29FDCF
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.